Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Achillion Pharmaceuticals Names General Counsel and SVP of Regulatory Affairs

Scuttlebutt | February 8, 2016

Achillion Pharmaceuticals has announced the addition of two members to the senior management team, including the appointment of a new general counsel and secretary, and a new senior vice president of regulatory affairs.

Martha Manning joined Achillion in February as general counsel. Previously, she held the same role from 2013 to 2016 at iCeutica, a drug development company. Prior to that, she served as chief legal officer of OraPharma, a J&J spinout company, from 2011 to 2012, when the company was acquired by Valeant. She joined OraPharma from Sandoz, the generic pharmaceutical division of Novartis, where she served as general counsel from 2008 to 2011.

Amy Jennings joined Achillion in January and serves as SVP of Regulatory Affairs. She was previously with Sanofi, where she was the head of U.S. regulatory for diabetes. Prior to Sanofi,...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.